Adverse effect of chronic tonsillitis on clinical course of sarcoidosis. 1991

T Ikeda, and N Daimaru, and S Inutsuka, and S Hayashi, and N Shigematsu, and T Nakashima, and T Uemura
Research Institute for Diseases of the Chest, Faculty of Medicine, Kyushu University, Fukuoka, Japan.

Sarcoidosis resolves spontaneously in many cases on a long-term basis. However, there are many cases whose resolution is delayed. We have experienced a frequent association of chronic tonsillitis (CTL), and dental caries in those patients of persistent course. We hypothesized that the presence of chronic or recurrent inflammatory foci in the upper airway may adversely affect the natural resolution of sarcoidosis. We analyzed the difference of regression of bilateral hilar lymphadenopathy on chest roentgenogram (CXR) in relation to changes in serum angiotensin converting enzyme (SACE) in sarcoidosis patients with and without CTL, and the effect of tonsillectomy (TLT) on the clinical course. In this study, we focused only on the tonsil for the sake of simplicity of analysis. Sarcoidosis resolved spontaneously in 10 of 28 (36%) patients with CTL and in 19 of 25 (76%) without CTL, and after TLT 9 cases became favorable in the course and the rate of unfavorable turned similar to those without CTL. The presence of CTL may be adversely related to the resolution of sarcoidosis.

UI MeSH Term Description Entries
D007703 Peptidyl-Dipeptidase A A peptidyl-dipeptidase that catalyzes the release of a C-terminal dipeptide, oligopeptide-|-Xaa-Yaa, when Xaa is not Pro, and Yaa is neither Asp nor Glu. Thus, conversion of ANGIOTENSIN I to ANGIOTENSIN II, with increase in vasoconstrictor activity, but no action on angiotensin II. It is also able to inactivate BRADYKININ, a potent vasodilator; and has a glycosidase activity which releases GPI-anchored proteins from the membrane by cleaving the mannose linkage in the GPI moiety. (From https://www.uniprot.org April 15, 2020). ACE1 Angiotensin-Converting Enzyme 1,ACE1 Protein,Angiotensin Converting Enzyme,Angiotensin Converting Enzyme 1,Antigens, CD143,CD143 Antigens,Dipeptidyl Carboxypeptidase I,Kininase II,Peptidase P,Angiotensin I-Converting Enzyme,Carboxycathepsin,Dipeptidyl Peptidase A,Kininase A,ACE1 Angiotensin Converting Enzyme 1,Angiotensin I Converting Enzyme,Carboxypeptidase I, Dipeptidyl,Peptidyl Dipeptidase A
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D002908 Chronic Disease Diseases which have one or more of the following characteristics: they are permanent, leave residual disability, are caused by nonreversible pathological alteration, require special training of the patient for rehabilitation, or may be expected to require a long period of supervision, observation, or care (Dictionary of Health Services Management, 2d ed). For epidemiological studies chronic disease often includes HEART DISEASES; STROKE; CANCER; and diabetes (DIABETES MELLITUS, TYPE 2). Chronic Condition,Chronic Illness,Chronically Ill,Chronic Conditions,Chronic Diseases,Chronic Illnesses,Condition, Chronic,Disease, Chronic,Illness, Chronic
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000293 Adolescent A person 13 to 18 years of age. Adolescence,Youth,Adolescents,Adolescents, Female,Adolescents, Male,Teenagers,Teens,Adolescent, Female,Adolescent, Male,Female Adolescent,Female Adolescents,Male Adolescent,Male Adolescents,Teen,Teenager,Youths
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D001419 Bacteria One of the three domains of life (the others being Eukarya and ARCHAEA), also called Eubacteria. They are unicellular prokaryotic microorganisms which generally possess rigid cell walls, multiply by cell division, and exhibit three principal forms: round or coccal, rodlike or bacillary, and spiral or spirochetal. Bacteria can be classified by their response to OXYGEN: aerobic, anaerobic, or facultatively anaerobic; by the mode by which they obtain their energy: chemotrophy (via chemical reaction) or PHOTOTROPHY (via light reaction); for chemotrophs by their source of chemical energy: CHEMOLITHOTROPHY (from inorganic compounds) or chemoorganotrophy (from organic compounds); and by their source for CARBON; NITROGEN; etc.; HETEROTROPHY (from organic sources) or AUTOTROPHY (from CARBON DIOXIDE). They can also be classified by whether or not they stain (based on the structure of their CELL WALLS) with CRYSTAL VIOLET dye: gram-negative or gram-positive. Eubacteria

Related Publications

T Ikeda, and N Daimaru, and S Inutsuka, and S Hayashi, and N Shigematsu, and T Nakashima, and T Uemura
March 1992, Chest,
T Ikeda, and N Daimaru, and S Inutsuka, and S Hayashi, and N Shigematsu, and T Nakashima, and T Uemura
January 1953, Vestnik otorinolaringologii,
T Ikeda, and N Daimaru, and S Inutsuka, and S Hayashi, and N Shigematsu, and T Nakashima, and T Uemura
September 1968, Vrachebnoe delo,
T Ikeda, and N Daimaru, and S Inutsuka, and S Hayashi, and N Shigematsu, and T Nakashima, and T Uemura
January 1969, Pediatriia akusherstvo i ginekologiia,
T Ikeda, and N Daimaru, and S Inutsuka, and S Hayashi, and N Shigematsu, and T Nakashima, and T Uemura
March 1955, Klinicheskaia meditsina,
T Ikeda, and N Daimaru, and S Inutsuka, and S Hayashi, and N Shigematsu, and T Nakashima, and T Uemura
January 2011, Vestnik otorinolaringologii,
T Ikeda, and N Daimaru, and S Inutsuka, and S Hayashi, and N Shigematsu, and T Nakashima, and T Uemura
December 1964, Sovetskaia meditsina,
T Ikeda, and N Daimaru, and S Inutsuka, and S Hayashi, and N Shigematsu, and T Nakashima, and T Uemura
July 1965, Pediatriia,
T Ikeda, and N Daimaru, and S Inutsuka, and S Hayashi, and N Shigematsu, and T Nakashima, and T Uemura
January 1977, Problemy tuberkuleza,
T Ikeda, and N Daimaru, and S Inutsuka, and S Hayashi, and N Shigematsu, and T Nakashima, and T Uemura
January 1967, Problemy tuberkuleza,
Copied contents to your clipboard!